Clinical Trial Update: MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer [NA]

View source ↗

Summary

This ClinicalTrials.gov study assesses MRI screening for brain metastases in patients with triple-negative or HER2-positive stage II/III breast cancer. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Breast Cancer | NA | Status: RECRUITING